Kate Byth, PhD, MA

Odyssey Therapeutics
Boston, MA, United States

www.linkedin.com/in/
kate-byth-19151910

Presentation(s):

• 2505: Discovery of First-in-Class IRAK4 Scaffolding Inhibitors for the Treatment of Inflammatory Disorders

  Tuesday, November 14, 2023
  4:30 PM – 4:40 PM PT

  Disclosure information not submitted.